The SURPASS registry (ClinicalTrials.gov; identifier NCT03286400) was an observational, prospective, single-arm, post-market, international study that enrolled patients undergoing thoracic endovascular aortic repair (TEVAR). A team of researchers from from University of Münster and Charité University Medicine Berlin has published one-year results of the SURPASS registry last year. They evaluated the performance of the Conformable TAG (CTAG) stent-graft with the Active …
Global initiative and network